New drug NTR-1011 tested for autoimmune diseases
NCT ID NCT07237659
First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times
Summary
This early-stage trial tested the safety of a new drug called NTR-1011 in 36 healthy adults and people with lupus or rheumatoid arthritis. The study aimed to find a safe dose and see how the drug behaves in the body. It is a first step toward possibly developing a new treatment for these autoimmune conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NTR-1011
- What this could lead to
- If successful, this could point toward a new treatment option for lupus and rheumatoid arthritis by controlling the immune system's attack on the body.
- What could go wrong
- This is a very early Phase 1 trial with only 36 people, focused on safety. It is too soon to know if NTR-1011 will work for patients, and many early-stage drugs fail to show benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RA - RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Attune Health Research Inc
RECRUITINGBeverly Hills, California, 90211, United States
-
Carewell Arthritis Center
RECRUITINGApple Valley, California, 92307, United States
-
Covina Arthritis Clinic
RECRUITINGCovina, California, 91722, United States
Contact Email: •••••@•••••
-
Foothill Arthritis Clinic
RECRUITINGTujunga, California, 91042, United States
-
Novamed
RECRUITINGMonterey Park, California, 91752, United States
-
Southland Arthritis Clinic
RECRUITINGRiverside, California, 92508, United States
-
Southland Arthritis Clinic
RECRUITINGTemecula, California, 92592, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New lupus drug CUG252 passes first safety check in small trial
- New lupus drug candidate ISH0613 enters first human safety trial
- Engineered immune cells take on lupus in first human test
- Immune reset: CAR-T cells take on lupus and more
- Experimental CAR-T therapy takes aim at Hard-to-Treat lupus kidney disease
- New pill VENT-03 aims to calm lupus skin flares